Sun Pharma Advanced Research Company has informed that the Right Issue Committee of Director, authorized by board of directors, at its meeting on April 27, 2016 from 10:00 am to 10:30 am, has approved the allotment of 10,204,081 fully paid-up equity shares of face value of Re 1 each at a price of Rs. 245 per equity share (including a share premium of Rs 244 per equity share) issued on a Right basis, to all eligible applicants who have subscribed to the said issue and whose applications were valid.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 435.70 |
| Indegene | 486.80 |
| CMS Info Systems | 318.00 |
| JITF Infralogistics | 338.00 |
| Sagility | 42.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: